Flow cytometric analysis of lung cells from each treatment revealed that EGFR-VHH-EVs loaded with miR-125b ASO demonstrated the best tumor suppressive effects, averaging at ~5% of tumor cells in the lung compared to 25-30% in the untreated and NC ASO-EV treated mice and 15-20% in untargeted miR-125b ASO-EV treated mice (Figure 6D). Here, EGFR is linked to neoplasm.